Medical Training AISenolytic Therapies Study Track
You'll be able to explain senescent cell biology and evaluate senolytic intervention approaches with a clinician's eye for evidence and risk.
What this track covers
This track covers the biology of cellular senescence and the senescence-associated secretory phenotype (SASP), how senolytic compounds are thought to work, and the reasoning clinicians use to weigh emerging interventions against uncertainty in the evidence base. It's built for clinicians who want a working framework for patient questions and literature review, not a protocol to prescribe from.
What you will practice
- Distinguish senescent cells from quiescent or apoptotic cells based on markers and behavior
- Explain the SASP and its downstream inflammatory and tissue effects to a patient in plain language
- Compare the proposed mechanisms of different senolytic compound classes
- Identify gaps and limitations in current senolytic evidence before making claims
- Frame a risk-benefit conversation with a patient asking about senolytic interventions
Simulator scenario
A patient who read about senolytics online asks a virtual clinician whether they should try them, requiring the learner to explore goals, evidence limitations, and safe next steps.
Board question topics
- Mechanisms of cellular senescence and cell-cycle arrest
- Components and effects of the SASP
- Proposed mechanisms of senolytic compound classes
- Interpreting evidence quality in emerging longevity interventions
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free